Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.

Autor: Schreuer, Max1 max.schreuer@uzbrussel.be, Meersseman, Geert2, Van Den Herrewegen, Sari2, Jansen, Yanina1, Chevolet, Ines3, Bott, Ambre1, Wilgenhof, Sofie1, Seremet, Teofila1, Jacobs, Bart2, Buyl, Ronald4, Maertens, Geert2, Neyns, Bart1
Zdroj: Journal of Translational Medicine. 4/19/2016, Vol. 14, p1-11. 11p.
Databáze: Academic Search Ultimate